Status in the Senate for the 91st Legislature (2019 - 2020)
Insulin products commissioner of health costs review authorization; excess costs determination; maximum reimbursement level establishment; appropriation
01/22/2019 | |
01/22/2019 |
Referred to Health and Human Services Finance and Policy
|